Recital 14, Regulation (EU) 2024/568

In forcesince 7 Feb 2024

In order to take into account all the marketing authorisations for medicinal products granted to marketing authorisation holders, the number of chargeable units corresponding to those authorisations should take into account the number of Member States in which each marketing authorisation is valid.